Showing results (1911-1920 of 2,209) with videos related to

Sort By:
Pageof 221
Journal of Medical Internet Research|September 30, 2022
The Impact of a Clinical Decision Support System for Addressing Physical Activity and Healthy Eating During Smoking Cessation Treatment: Hybrid Type I Randomized Controlled TrialNadia Minian, Mathangee Lingam, Rahim Moineddin, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 28, 2022
Academic Productivity of Equity-Deserving Physician Scholars During COVID-19: A Scoping ReviewSophie Soklaridis, Georgia Black, Constance LeBlanc, et al.
Molecular Cancer Research : MCR|May 10, 2017
Regulation of USP37 Expression by REST-Associated G9a-Dependent Histone MethylationTara H W Dobson, Rashieda J Hatcher, Jyothishmathi Swaminathan, et al.
Vaccine|April 3, 2001
Proinflammatory cytokine expression by Theileria annulata infected cell lines correlates with the pathology they cause in vivoS P Graham, D J Brown, Z Vatansever, et al.
Schizophrenia Bulletin|January 1, 1994
Prenatal origin of schizophrenia in a subgroup of discordant monozygotic twinsE F Torrey, E H Taylor, H S Bracha, et al.
Molecular Ecology|January 1, 2018
A candidate tolerance gene identified in a natural population of field voles (Microtus agrestis)Klara M Wanelik, Michael Begon, Richard J Birtles, et al.
IEEE Transactions on Medical Robotics and Bionics|August 8, 2025
SlicerROS2: A research and development module for image-guided robotic interventionsLaura Connolly, Aravind S Kumar, Kapi Ketan Mehta, et al.
JAMA Psychiatry|July 8, 2026
Pharmacological Interventions for Weight Reduction in Patients With Schizophrenia Treated With Antipsychotics: A Systematic Review and Network Meta-AnalysisNicolette Stogios, Sri Mahavir Agarwal, Kateryna Maksyutynska, et al.
Leukemia|August 11, 2006
Differential DNA methylation patterns of small B-cell lymphoma subclasses with different clinical behaviorF B Rahmatpanah, S Carstens, J Guo, et al.
Oncotarget|November 20, 2019
Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm studySarina A Piha-Paul, Matthew H Taylor, Daniel Spitz, et al.
Pageof 221